Cargando…
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness
Intratumoral heterogeneity, including in clear cell renal cell carcinoma, is a potential cause of drug resistance and metastatic cancer progression. We specified the heterogeneous population marked by endoglin (also known as CD105) in a preclinical model of clear cell renal cell carcinoma progressio...
Autores principales: | Momoi, Yusaku, Nishida, Jun, Miyakuni, Kosuke, Kuroda, Masafumi, Kubota, Shimpei I., Miyazono, Kohei, Ehata, Shogo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353946/ https://www.ncbi.nlm.nih.gov/pubmed/34091990 http://dx.doi.org/10.1111/cas.15007 |
Ejemplares similares
-
An in vivo orthotopic serial passaging model for a metastatic renal cancer study
por: Nishida, Jun, et al.
Publicado: (2022) -
Genome‐wide analysis of DNA methylation identifies the apoptosis‐related gene UQCRH as a tumor suppressor in renal cancer
por: Miyakuni, Kosuke, et al.
Publicado: (2021) -
c‐Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling
por: Taguchi, Luna, et al.
Publicado: (2019) -
Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms
por: Nishida, Jun, et al.
Publicado: (2018) -
Protocol for Imaging and Analysis of Mouse Tumor Models with CUBIC Tissue Clearing
por: Takahashi, Kei, et al.
Publicado: (2020)